Hunan Warrant Pharmaceutical Co Ltd
SSE:688799

Watchlist Manager
Hunan Warrant Pharmaceutical Co Ltd Logo
Hunan Warrant Pharmaceutical Co Ltd
SSE:688799
Watchlist
Price: 49.98 CNY 2% Market Closed
Market Cap: 6.6B CNY

Net Margin
Hunan Warrant Pharmaceutical Co Ltd

10.6%
Current
14%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
10.6%
=
Net Income
145.5m
/
Revenue
1.4B

Net Margin Across Competitors

No Stocks Found

Hunan Warrant Pharmaceutical Co Ltd
Glance View

Market Cap
6.6B CNY
Industry
Pharmaceuticals

Hunan Warrant Pharmaceutical Co., Ltd. engages in the production of Chinese medicine. The company is headquartered in Changsha, Hunan and currently employs 1,103 full-time employees. The company went IPO on 2021-07-13. The firm's products include pharmaceutical preparations, raw materials and intermediates, plant extracts and food. Its products cover areas such as digestion, breathing, and anti-infection. The firm mainly conducts business within the domestic market.

Intrinsic Value
35.41 CNY
Overvaluation 29%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
10.6%
=
Net Income
145.5m
/
Revenue
1.4B
What is the Net Margin of Hunan Warrant Pharmaceutical Co Ltd?

Based on Hunan Warrant Pharmaceutical Co Ltd's most recent financial statements, the company has Net Margin of 10.6%.

Back to Top